White Label vs Private Label for Peptides

the terms get used interchangeably and they should not be, because the difference determines your moq, your lead time, your margin, and whether you are building an asset or renting one. white label: a supplier already makes a product, and they will put your label on it. private label: you write a specification and they manufacture to it. the product might look similar on a shelf. the businesses are not similar at all.

operations and business article, not legal or medical advice. either route requires legitimate documented suppliers, verified testing, and attorney-reviewed labeling. neither route lets you skip that.

side by side

• —MOQ — white label commonly a few dozen to a few hundred units. private label commonly several hundred to several thousand per sku.
• —lead time — white label 1-3 weeks, mostly label printing. private label 6-14 weeks including production and often custom packaging.
• —unit cost — white label higher per unit because the supplier keeps the manufacturing margin. private label lower at volume, but with real setup costs to amortize.
• —control — white label gives you the label and nothing else. private label gives you concentration, fill volume, vial format, packaging and often the testing scope.
• —differentiation — white label none at the product level; your competitor may be selling the identical unit. private label real, because the spec is yours.
• —capital at risk — white label low. private label meaningful, and tied up for months.
• —defensibility — white label thin. private label is an actual asset with a supply agreement behind it.

when white label is the right call

white label is a validation tool. it answers the questions that matter before you commit capital.

• —you have not yet proven that your audience buys this sku at your price.
• —you want to test three or four products to find which one has repeat purchase, without ordering three or four production runs.
• —cash is the binding constraint and you would rather put it into acquisition than into a fridge.
• —you need revenue in weeks, not a quarter, to fund the next step.
• —you are testing a market you do not fully understand yet and want optionality.

the honest downside: your margin is thinner, you cannot differentiate on the product itself, and if you build an audience on a white label sku, the supplier can sell the same unit to the competitor who outbids you next quarter. treat white label as a stage, not a destination.

when private label is the right call

• —a sku has proven repeat purchase — customers are buying it twice, not just once.
• —your volume makes the moq comfortable rather than terrifying. a good test: can you clear the moq in 90-120 days at current velocity?
• —your paid social is working and unit economics are the constraint. the margin difference between white and private label is often the difference between a viable cac and an unviable one.
• —you want a spec competitors cannot copy off a supplier catalog — a specific concentration, fill or format.
• —you are building toward something with enterprise value, not just cash flow.

that curve is what makes the private label transition urgent rather than optional. once acquisition is working, every point of gross margin compounds into more spend you can afford, and white label margin caps how far the account can scale.

the margin math

make the decision on numbers rather than on how the words feel. run both scenarios at your realistic volume.

1. 1.white label: unit cost at your moq, plus label print, plus fulfillment, plus shipping and packout. that is your landed cost.
2. 2.private label: unit cost at your moq, plus fill-finish if separate, plus vials and closures, plus label and carton print including one-time plate and die costs, plus per-lot testing, plus inbound freight and duty, plus fulfillment and packout. amortize the one-time costs across the units you will actually sell before expiry, not across the full order.
3. 3.compare landed cost as a percentage of your retail price. you want to be at or under roughly 20-25% on a core sku.
4. 4.then layer in the cost of capital: private label ties up cash for months. price that honestly against what the same cash would earn in ad spend.
5. 5.and layer in expiry risk: units you will not clear before dating are a write-off, so use realistic velocity, not aspirational.

the common trap is comparing quoted unit price only. a private label unit that looks 35% cheaper can land nearly even once you spread plates, dies, testing and freight across a first order you will take five months to sell. the second order is where the economics actually arrive, because the one-time costs are already paid.

the hybrid most brands actually run

the practical answer for most operators is not either-or. run your one or two proven heroes as private label, where volume justifies the moq and margin matters most, and keep long-tail or experimental skus white label so you can test without committing. as a test sku proves out, promote it into private label. as a private label sku fades, run down the inventory rather than reordering. that portfolio approach gives you the margin where it counts and the optionality where you need it.

what does not change between the two

• —you still need lot-specific third-party coas. white labeling someone else's product does not outsource the responsibility — your name is on the vial.
• —you still verify the coa with the issuing lab and test lot one independently.
• —you still need attorney-reviewed label copy. the supplier's existing label is not automatically compliant for your channel or your claims.
• —you still need cold chain and lot-level fulfillment.
• —you still own every customer complaint, chargeback and regulatory question that comes out of it.

white label rents you a product. private label builds you one. both put your name on the outcome.

the differentiation you still control on white label

if you are running white label, the product is not your differentiator, so everything else has to be. that means packaging that looks better than the category norm, a coa lookup your competitors do not offer even on the same unit, faster and more human support, a replenishment experience that actually anticipates when someone runs out, and content that demonstrates you understand the category rather than reciting supplier copy. brands have built serious businesses on white label product purely because the surrounding experience was two levels above everyone else selling the identical vial. what you cannot do is compete on price — with an identical unit and a thinner margin, a price war is a race you have already lost.

how to make the switch cleanly

1. 1.pick the one sku with the strongest repeat purchase. do not convert the catalog at once.
2. 2.write the spec you actually want, rather than copying the white label product's spec by default. this is your one chance to improve fill volume, concentration or format.
3. 3.qualify the manufacturer properly — full document request, coa verification, independent sample test.
4. 4.run artwork and legal review in parallel with supplier qualification, because artwork is usually the long pole.
5. 5.time the first private label order to land before white label stock runs down, with a small overlap buffer.
6. 6.sell through the white label stock first so you are not holding two versions of the same product.
7. 7.tell customers something changed if anything material changed — format, fill, concentration. quiet substitution generates support tickets and suspicion.

done well the transition is invisible to customers except that the packaging gets better and the product stays consistent. done badly it produces a month of mixed inventory, confused reorders and a support queue full of people asking why their vial looks different.